R. Ertas Et Al. , "Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6, pp.1255-1262, 2018
Ertas, R. Et Al. 2018. Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6 , 1255-1262.
Ertas, R., Ozyurt, K., Karakukcu, Ç., Akkus, M. R., Ozlu, E., Avci, A., ... Atasoy, M.(2018). Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria. TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6, 1255-1262.
Ertas, Ragip Et Al. "Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria," TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6, 1255-1262, 2018
Ertas, Ragip Et Al. "Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6, pp.1255-1262, 2018
Ertas, R. Et Al. (2018) . "Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria." TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.6, pp.1255-1262.
@article{article, author={Ragip Ertas Et Al. }, title={Evaluation of platelet parameters and neutrophil/lymphocyte ratio during omalizumab treatment in patients with severe chronic spontaneous urticaria}, journal={TURKISH JOURNAL OF MEDICAL SCIENCES}, year=2018, pages={1255-1262} }